These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Harnessing the power of antibodies for therapeutic applications was a question of time. Grillo-Lopez AJ; McClure A; Dallaire BK Curr Pharm Biotechnol; 2001 Dec; 2(4):277-8. PubMed ID: 11762409 [No Abstract] [Full Text] [Related]
24. Advances in cancer control: cancer control research and the emergence of the oncology product line. Proceedings of the 5th annual meeting on Advances in Cancer Control--a combined meeting of the Association of Community Cancer Centers/Association of American Cancer Institutes. Washington, D.C., March 11-15, 1987. Prog Clin Biol Res; 1988; 278():1-253. PubMed ID: 3211929 [No Abstract] [Full Text] [Related]
25. [Antibody and immunotherapy in oncology. Which patients benefit?]. Schlimok G MMW Fortschr Med; 2001 Jun; 143(25):24-8. PubMed ID: 11468992 [TBL] [Abstract][Full Text] [Related]
26. Recent progress in the use of monoclonal antibodies for imaging and therapy. Monson JR Curr Opin Gen Surg; 1993; ():334-9. PubMed ID: 7584004 [TBL] [Abstract][Full Text] [Related]
27. In vivo diagnosis and therapy of human tumors with monoclonal antibodies. Part II. Proceedings of a symposium. Naples, Italy, 16-19 March 1988. Int J Rad Appl Instrum B; 1989; 16(6):613-68. PubMed ID: 2606717 [No Abstract] [Full Text] [Related]
28. Monoclonal antibodies in clinical hematology and oncology. Nagorsen D; Thiel E Curr Opin Investig Drugs; 2007 Dec; 8(12):996-1001. PubMed ID: 18058570 [TBL] [Abstract][Full Text] [Related]
29. Advances in the applications of monoclonal antibodies in clinical oncology. University of London Royal Postgraduate Medical School. 8th-10th May, 1985. Abstracts. Br J Cancer; 1985 Oct; 52(4):641-68. PubMed ID: 4063142 [No Abstract] [Full Text] [Related]
30. Basic principles and applications of monoclonal antibodies in the management of carcinomas: the Richard and Hinda Rosenthal Foundation award lecture. Schlom J Cancer Res; 1986 Jul; 46(7):3225-38. PubMed ID: 3518915 [No Abstract] [Full Text] [Related]
31. Advances in cancer: antibody targeting of cancer--prospects for detection and therapy. Goldenberg DM N J Med; 1987 Mar; 84(3):195-8. PubMed ID: 3550534 [No Abstract] [Full Text] [Related]
32. Third international Dresden symposium on immunotherapy of cancer. Schmitz M; Bornhauser M; Ockert D; Rieber EP Cancer Res; 2001 Apr; 61(8):3524-8. PubMed ID: 11309317 [No Abstract] [Full Text] [Related]
33. Targeted therapies: cui prodest? Ferrari D; Foa P J Clin Oncol; 2007 Oct; 25(29):4691-2; author reply 4692. PubMed ID: 17925568 [No Abstract] [Full Text] [Related]
34. Advances in the applications of monoclonal antibodies in clinical oncology. London, 28-30 May 1986. Br J Cancer; 1986 Sep; 54(3):525-56. PubMed ID: 3756088 [No Abstract] [Full Text] [Related]
35. Prospects for the therapeutic use of human monoclonal antibodies. Larrick JW; Bourla JM J Biol Response Mod; 1986 Oct; 5(5):379-93. PubMed ID: 3534144 [TBL] [Abstract][Full Text] [Related]
36. [Current status and perspectives of immunodiagnosis and immunotherapy in oncology]. Pfreundschuh M Med Klin (Munich); 1987 Apr; 82(9):320-9. PubMed ID: 3600548 [No Abstract] [Full Text] [Related]
37. Potential clinical utility of monoclonal antibodies in the management of human carcinomas. Schlom J; Weeks MO Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739 [No Abstract] [Full Text] [Related]
38. 5th Annual Monoclonal Antibodies Conference: March 24-25, 2009, London, UK. Herigstad M; Urquhart L MAbs; 2009; 1(4):308-17. PubMed ID: 20073132 [TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies. Elias EG Md Med J; 1986 Jul; 35(7):553. PubMed ID: 3747747 [No Abstract] [Full Text] [Related]
40. Principles of the therapeutic use of monoclonal antibodies in oncology. Fridman WH C R Biol; 2006 Apr; 329(4):255-9. PubMed ID: 16644495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]